Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Phio Pharmaceuticals Corp. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 500.7K | 700.4K | +199.7K (+39.9%) |
| Value | $1.34M | $1.58M | +$240.0K (+17.9%) |
New holders (6)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 41,873 | $95.0K | 0.00% |
| Goldman Sachs Group Inc | 19,002 | $43.0K | 0.00% |
| Two Sigma Securities, LLC | 17,099 | $39.0K | 0.01% |
| Millennium Management LLC | 10,035 | $23.0K | 0.00% |
| UBS Group AG | 1,377 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 684 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 132,333 | $355.0K |
| Susquehanna Fundamental Investments, LLC | 17,800 | $48.0K |
| Valeo Financial Advisors, LLC | 4,000 | $11.0K |
| Spire Wealth Management | 2,000 | $6.00K |
| Total Clarity Wealth Management, Inc. | 1,500 | $4.00K |